Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Drug Licensing Division To Be Headed By Ex-Pharmacia Exec

Executive Summary

Ex-Pharmacia exec Michael DuBois will head Schering-Plough's newly formed product licensing division

You may also be interested in...



Schering Will Audit Compliance With Anti-Bribery Law Under SEC Settlement

Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission

Schering Will Audit Compliance With Anti-Bribery Law Under SEC Settlement

Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission

Amgen As Model For Corporate Governance: CEO Says Ignorance Is No Excuse

CEOs should not be permitted to argue that they are ignorant of ethical deviations within their companies, Amgen CEO Kevin Sharer declared Jan. 14 during the J.P. Morgan health care conference in San Francisco

Related Content

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel